Publications by authors named "Bethany D Latham"

Claim this Profile
N
N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation.
Raeanne M Lanphier, Bethany D Latham, Amanda J Gerringer, Tyler Interrante, Corbin D Jones

Drug Metab Dispos· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of variation in CYP3A and CYP2C8 on tucatinib metabolic clearance in human liver microsomes.
Bethany D Latham, Pegah Montazeri, Licza F Lobo, John K Fallon, Klarissa D Jackson

Drug Metab Dispos· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities.
Bethany D Latham, Raeanne M Geffert, Klarissa D Jackson

Drug Metab Dispos· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO CAN USE YOUR CELLS OR TISSUES FOR SCIENTIFIC RESEARCH?
Jessica L Beers, Raeanne M Geffert, Bethany D Latham, Klarissa D Jackson

Front Young Minds· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
Klarissa D Jackson, Brahim Achour, Jonghwa Lee, Raeanne M Geffert, Jessica L Beers, Bethany D Latham

Drug Metab Dispos· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib.
Bethany D Latham, D Spencer Oskin, Rachel D Crouch, Matthew J Vergne, Klarissa D Jackson

Chem Res Toxicol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis